Complera Drug Interactions: 228 Major, 823 Moderate
Complera (Emtricitabine, Rilpivirine Hydrochloride, And Tenofovir Disoproxil Fumarate) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Complera. Always confirm against the full prescribing information.
100 interactions
Abatacept
The metabolism of Rilpivirine can be increased when combined with Abatacept.
Level 1 evidence
Abemaciclib
The serum concentration of Abemaciclib can be increased when it is combined with Tenofovir disoproxil.
Level 2 evidence
Abrocitinib
The serum concentration of Tenofovir disoproxil can be increased when it is combined with Abrocitinib.
Level 2 evidence
Abrocitinib
The metabolism of Abrocitinib can be decreased when combined with Rilpivirine.
Level 2 evidence
Acalabrutinib
The serum concentration of Rilpivirine can be increased when it is combined with Acalabrutinib.
Level 1 evidence
Acebutolol
The metabolism of Acebutolol can be decreased when combined with Rilpivirine.
Level 2 evidence
Acenocoumarol
The serum concentration of Acenocoumarol can be increased when it is combined with Rilpivirine.
Level 1 evidence
Acetaminophen
The serum concentration of Rilpivirine can be increased when it is combined with Acetaminophen.
Level 1 evidence
Acetylsalicylic acid
The metabolism of Acetylsalicylic acid can be decreased when combined with Rilpivirine.
Level 2 evidence
Adagrasib
The serum concentration of Tenofovir disoproxil can be increased when it is combined with Adagrasib.
Level 2 evidence
Adalimumab
The metabolism of Rilpivirine can be increased when combined with Adalimumab.
Level 1 evidence
Adenovirus type 7 vaccine live
The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Emtricitabine.
Level 2 evidence
Adenovirus type 7 vaccine live
The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Rilpivirine.
Level 2 evidence
Adenovirus type 7 vaccine live
The therapeutic efficacy of Adenovirus type 7 vaccine live can be decreased when used in combination with Tenofovir disoproxil.
Level 2 evidence
Enter your NPI to unlock 11 major interactions for Complera
Complera (Emtricitabine, Rilpivirine Hydrochloride, And Tenofovir Disoproxil Fumarate) has 1984 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Complera (Emtricitabine, Rilpivirine Hydrochloride, And Tenofovir Disoproxil Fumarate) has 228 major, 823 moderate, and 933 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Complera. Always confirm against the full prescribing information.